Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis
In comparison with PA-HAIC alone, PA-HAIC combined with PD-1 inhibitors could improve the DFS benefits with acceptable safety profiles in HCC patients with MVI.
Authors
- Qinyan Yang (ORCID: https://orcid.org/0000-0002-1835-4355)
- Yuxin Liang (ORCID: https://orcid.org/0000-0001-6872-5030)
- Yuhao Su
- Deyuan Zhong
- Jin Shang
- Hongtao Yan
- Ya‐Hui Chen (ORCID: https://orcid.org/0000-0002-4117-773X)
- Xiaolun Huang (ORCID: https://orcid.org/0000-0002-4993-0802)
Institutions
- University of Electronic Science and Technology of China (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1186/s12885-025-13793-x
- Citations
- 2
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Sichuan Province Science and Technology Support Program